PREDICTORS OF FLARE IN RHEUMATOID ARTHRITIS PATIENTS TREATED PREVENTIVELY WITH RITUXIMAB: A PROSPECTIVE STUDY USING ULTRASOUND AND PATIENT-REPORTED OUTCOMES

被引：0
|
作者：
Ismajli, Mediola [1 ]
Leandro, Maria [1 ]
机构：
[1] Univ Coll London Hosp, Rheumatol, London, England
来源：
RHEUMATOLOGY | 2017年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
234
引用
收藏
页码：143 / 143
页数：1
相关论文
共 50 条
  • [31] Patient adherence with a smartphone app for patient-reported outcomes in rheumatoid arthritis
    Colls, Josh
    Lee, Yvonne C.
    Xu, Chang
    Corrigan, Cassandra
    Lu, Fengxin
    Marquez-Grap, Georgia
    Murray, Meredith
    Suh, Dong H.
    Solomon, Daniel H.
    RHEUMATOLOGY, 2021, 60 (01) : 108 - 112
  • [32] Patient-reported outcomes (pro) in rheumatoid arthritis (RA) patients treated with etanercept (enbrel®) for up to 5 years
    Fleischmann, RM
    Baumgartner, SW
    Moreland, LW
    Schiff, MH
    Markenson, JA
    Wanke, LA
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 419 - 419
  • [33] Patient-reported outcomes of upadacitinib versus abatacept in rheumatoid arthritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2022, 4 (08): : E531 - E531
  • [34] Relationship of patient-reported outcomes with MRI measures in rheumatoid arthritis
    Baker, Joshua F.
    Conaghan, Philip G.
    Emery, Paul
    Baker, Daniel G.
    Ostergaard, Mikkel
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (03) : 486 - 490
  • [35] Patient-reported outcomes and their-role in the assessment of rheumatoid arthritis
    Lubeck, DP
    PHARMACOECONOMICS, 2004, 22 (02) : 27 - 38
  • [36] Sustained improvements in patient-reported outcomes in psoriatic arthritis patients treated with etanercept
    Mease, P
    Gottlieb, A
    Woolley, JM
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P2 - P2
  • [37] Patient-reported Outcomes and Quality of Life in Patients with Rheumatoid Arthritis Treated with GP2015: Final Results from a Realworld Study
    Askari, Ayman
    Schmalzing, Marc
    Kellner, Herbert
    Ortega-Castro, Rafaela
    Perez-Coleman, Julio Cesar Vazquez
    Rosario, Foti
    Jeka, Slawomir
    Haraoui, Boulos
    Allanore, Yannick
    Rahman, Masiur
    Furlan, Fabricio
    Hachaichi, Sohaib
    Sheeran, Tom
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 353 - 354
  • [38] THE PRESENCE OF COMORBIDITIES IN PATIENTS WITH RHEUMATOID ARTHRITIS IS ASSOCIATED WITH BAD PATIENT-REPORTED OUTCOMES (PROS)
    Pereira, I.
    Coan, T.
    Castro, G.
    Castelar, G.
    Vargas-Santos, A. B.
    Albuquerque, C.
    Gomides, A. P.
    Bertolo, M.
    Louzada, P., Jr.
    Giorgi, R.
    Radominsky, S.
    Guimaraes, M. F.
    Bonfiglioli, K.
    Sauma, M. D. F.
    Brenol, C.
    Coutinho, E.
    Mota, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 972 - 973
  • [39] PATIENT-REPORTED OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH SUBCUTANEOUS TOCILIZUMAB COMPARED WITH PLACEBO OR INTRAVENOUS TOCILIZUMAB IN COMBINATION WITH CSDMARDS
    Strand, V.
    Lampl, K.
    Birchwood, C.
    Pei, J.
    Tuckwell, K.
    Finch, R.
    Kivitz, A.
    Burmester, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 581 - 582
  • [40] Patient-reported outcomes (PRO) in rheumatoid arthritis (RA) patients treated with etanercept (ENBREL®) for up to 5 years.
    Fleischmann, RM
    Baumgartner, SW
    Moreland, LW
    Schiff, MH
    Markenson, J
    Spencer-Green, G
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S530 - S531
12345